It was reported that on two separate occasions, thirty minutes after receiving a flush from a bd posiflush¿ normal saline syringe, a patient experienced ¿a severe reaction including coughing, couldn't breathe and cold sweats¿.The patient went to the emergency room on both occasions but was told that nothing could be determined.The patient has ¿requested and is waiting for approval to be tested for serratia¿.
|
H.6.Investigation summary: four samples were received by bd for evaluation.A quality engineer was able to inspect the samples and sent them out for ftir testing.The results of the testing were all negative and the samples passed each of test.The tests performed were an endotoxin test, ph test, sterility test, and heavy metals and iron testing.All samples were found to be within specifications and there was no observed bacterial growth when plated and incubated.Bd was unable to identify a cause for the reported issue.Bd has placed controls in their manufacturing plants to prevent contamination such as weekly bioburden testing, an overkill sterilization process, biweekly environmental testing with the filling area, the solutions are filtered twice before filling, each sterilizer was thoroughly validated before use and a continuous online monitoring of the wfi water quality.A review of the device history record of batch 7348542 revealed zero defects found during this production run.Capa not required for this event.Complaints received for this product and condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business regularly reviews the collected data for identification of emerging trends.
|